Nationwide Children’s AI spinoff acquired by $200M startup connecting patients with clinical trials


Columbus-based Deep Lens Inc. joins New York City startup Paradigm Health Inc. to build technology that improves access to and diversity in clinical trials.

Previous Medical technology firm Orchestra BioMed listed on Nasdaq after finalizing SPAC merger
Next Cincinnati food truck Mexi-Q opens first restaurant in Mason: PHOTOS